Income Statement ImmuCell Corporation

Stocks

ICCC

US4525253062

Pharmaceuticals

Market Closed - Nasdaq 04:00:00 2026-09-18 pm EDT			5-day change	1st Jan Change
9.950 ^USD	-0.30%		+1.02%	+61.79%

Aug. 14	ImmuCell Corporation, Q2 2026 Earnings Call, Aug 14, 2026
Aug. 13	ImmuCell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

c3c3651954d67d7560811bfcbb8.2ox79PDvDEIfRZgzO1YUtc-krLHxLQEfz-RLJotdwfI.s-Q2xJSwaHJSHNpETi583Yjv_IalFW1tmp0bbNgnm8WUxyyGgJpib3cw1Q

Published financial data: IMMUCELL CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	19.24M	18.57M	17.47M	26.49M	27.64M
Total Revenues	19.24M	18.57M	17.47M	26.49M	27.64M
Cost of Goods Sold, Total	10.59M	10.92M	13.08M	18.15M	16.2M
Gross Profit	8.66M	7.65M	4.4M	8.35M	11.45M
Selling General & Admin Expenses, Total	4.23M	5.45M	5.22M	5.68M	5.95M
R&D Expenses	4.17M	4.49M	4.39M	3.9M	3.04M
Other Operating Expenses, Total	8.4M	9.95M	9.62M	9.58M	9M
Operating Income	257K	-2.3M	-5.22M	-1.23M	2.45M
Interest Expense, Total	-314K	-349K	-476K	-569K	-493K
Interest And Investment Income	18.81K	153K	96.57K	77.7K	159K
Net Interest Expenses	-296K	-195K	-379K	-491K	-335K
Other Non Operating Income (Expenses)	-	912	107	-	3.78K
EBT, Excl. Unusual Items	-38.16K	-2.49M	-5.6M	-1.72M	2.12M
Restructuring Charges	-	-	-	-	-800K
Gain (Loss) On Sale Of Assets	-30.96K	7.33K	-8.1K	-15.39K	-106K
Asset Writedown	-	-	-	-	-2.67M
Insurance Settlements	-	-	365K	-	427K
Other Unusual Items	-	-	-527K	-407K	-
EBT, Incl. Unusual Items	-69.13K	-2.49M	-5.77M	-2.15M	-1.03M
Income Tax Expense	9.16K	7.67K	4.63K	10.06K	11.57K
Earnings From Continuing Operations	-78.29K	-2.49M	-5.77M	-2.16M	-1.04M
Net Income to Company	-78.29K	-2.49M	-5.77M	-2.16M	-1.04M
Net Income - (IS)	-78.29K	-2.49M	-5.77M	-2.16M	-1.04M
Net Income to Common Incl Extra Items	-78.29K	-2.49M	-5.77M	-2.16M	-1.04M
Net Income to Common Excl. Extra Items	-78.29K	-2.49M	-5.77M	-2.16M	-1.04M
Per Share Items
Net EPS - Basic	-0.01	-0.32	-0.75	-0.26	-0.12
Basic EPS - Continuing Operations	-0.01	-0.32	-0.75	-0.26	-0.12
Basic Weighted Average Shares Outstanding	7.59M	7.75M	7.75M	8.17M	9.03M
Net EPS - Diluted	-0.01	-0.32	-0.75	-0.26	-0.12
Diluted EPS - Continuing Operations	-0.01	-0.32	-0.75	-0.26	-0.12
Diluted Weighted Average Shares Outstanding	7.59M	7.75M	7.75M	8.17M	9.03M
Normalized Basic EPS	-0	-0.2	-0.45	-0.13	0.15
Normalized Diluted EPS	-0	-0.2	-0.45	-0.13	0.15
Supplemental Items
EBITDA	2.72M	189K	-2.5M	1.45M	5.18M
EBITA	276K	-2.28M	-5.2M	-1.21M	2.47M
EBIT	257K	-2.3M	-5.22M	-1.23M	2.45M
EBITDAR	2.88M	374K	-2.12M	1.95M	5.66M
Effective Tax Rate - (Ratio)	-13.26	-0.31	-0.08	-0.47	-1.12
Current Domestic Taxes	9.16K	7.67K	4.63K	10.06K	11.57K
Total Current Taxes	9.16K	7.67K	4.63K	10.06K	11.57K
Deferred Domestic Taxes	0	0	0	0	0
Total Deferred Taxes	0	0	0	0	0
Normalized Net Income	-23.85K	-1.56M	-3.5M	-1.08M	1.32M
Interest on Long-Term Debt	314K	349K	476K	569K	493K
Supplemental Operating Expense Items
Advertising Expense	37.82K	-	-	-	-
Selling and Marketing Expenses	2.5M	3.19M	3.09M	3.47M	3.55M
General and Administrative Expenses	1.73M	2.26M	2.13M	2.22M	2.4M
Research And Development Expense From Footnotes	4.17M	4.49M	4.39M	3.9M	3.04M
Net Rental Expense, Total	159K	186K	386K	494K	479K
Imputed Operating Lease Interest Expense	38.16K	45.48K	101K	141K	134K
Imputed Operating Lease Depreciation	121K	140K	285K	353K	345K
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	144K	266K	369K	326K	296K
Total Stock-Based Compensation	144K	266K	369K	326K	296K

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	10.19M	5.79M	979K	3.76M	3.81M
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	10.19M	5.79M	979K	3.76M	3.81M
Accounts Receivable, Total	2.69M	1.76M	2.19M	3.77M	3.42M
Other Receivables	26.48K	42.18K	39.73K	40.56K	31.18K
Total Receivables	2.72M	1.8M	2.23M	3.81M	3.45M
Inventory	3.09M	6.04M	7.81M	7.11M	9.27M
Prepaid Expenses	269K	364K	454K	360K	420K
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	16.26M	13.99M	11.47M	15.04M	16.94M
Gross Property Plant And Equipment	42M	46.51M	50.63M	50.95M	44.29M
Accumulated Depreciation	-13.99M	-15.88M	-18.48M	-21.04M	-18.84M
Net Property Plant And Equipment	28M	30.64M	32.15M	29.91M	25.45M
Long-term Investments	-	-	-	-	-
Goodwill	95.56K	95.56K	95.56K	95.56K	95.56K
Other Intangibles, Total	76.42K	57.31K	38.21K	19.1K	0
Deferred Tax Assets Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	26.12K	76.63K	57.66K	33.37K	37.69K
Total Assets	44.47M	44.86M	43.81M	45.1M	42.53M
Liabilities
Accounts Payable, Total	727K	727K	875K	935K	792K
Accrued Expenses, Total	867K	1.21M	1.23M	1.53M	1.48M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	812K	1.04M	1.43M	1.5M	1.61M
Current Portion of Leases	108K	31.76K	644K	432K	85.49K
Current Income Taxes Payable	2.14K	4.89K	3.05K	5.82K	6.69K
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	18.26K	63.26K	13.18K	8.75K	4.07K
Total Current Liabilities	2.53M	3.07M	4.2M	4.41M	3.98M
Long-Term Debt	8.33M	9.19M	10.54M	9.04M	7.49M
Long-Term Leases	1.03M	2.22M	4.08M	4.13M	4.01M
Total Liabilities	11.89M	14.48M	18.82M	17.58M	15.48M
Common Stock, Total	781K	781K	781K	904K	911K
Additional Paid In Capital	35.69M	35.98M	36.36M	40.92M	41.48M
Retained Earnings	-3.74M	-6.23M	-12.01M	-14.16M	-15.2M
Treasury Stock	-158K	-147K	-138K	-138K	-131K
Comprehensive Income and Other	-	-	-	-	-
Total Common Equity	32.58M	30.38M	24.99M	27.52M	27.06M
Total Equity	32.58M	30.38M	24.99M	27.52M	27.06M
Total Liabilities And Equity	44.47M	44.86M	43.81M	45.1M	42.53M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	7.74M	7.75M	7.75M	8.98M	9.05M
ECS Total Common Shares Outstanding	7.74M	7.75M	7.75M	8.98M	9.05M
Book Value / Share	4.21	3.92	3.22	3.06	2.99
Tangible Book Value	32.4M	30.23M	24.86M	27.4M	26.96M
Tangible Book Value Per Share	4.19	3.9	3.21	3.05	2.98
Total Debt	10.27M	12.48M	16.69M	15.1M	13.19M
Net Debt	89.03K	6.69M	15.71M	11.34M	9.39M
Debt Equivalent Oper. Leases	1.28M	1.48M	3.09M	3.95M	3.83M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	972K	2.42M	1.59M	1.36M	1.65M
Inventories - Work In Process, Total	1.9M	3.47M	5.82M	5.75M	5.75M
Inventories - Finished Goods, Total	216K	150K	403K	9.53K	1.87M
Land - (BS)	517K	517K	517K	517K	517K
Buildings, Total	19.12M	20.05M	20.78M	20.89M	20.9M
Machinery, Total	18.26M	20.08M	21.99M	22.29M	17.96M
Full Time Employees	60	67	74	69	73
Part Time Employees	7	7	5	6	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-
Order Backlog	2.4M	2.5M	9.4M	4.4M	9.4M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-78.29K	-2.49M	-5.77M	-2.16M	-1.04M
Depreciation & Amortization - CF	2.44M	2.47M	2.7M	2.67M	2.71M
Amortization of Goodwill and Intangible Assets - (CF)	19.1K	19.1K	19.1K	19.1K	19.1K
Depreciation & Amortization, Total	2.46M	2.49M	2.72M	2.69M	2.73M
Amortization of Deferred Charges, Total - (CF)	7.84K	7.66K	22.62K	42.67K	54.35K
(Gain) Loss From Sale Of Asset	30.96K	-7.33K	8.1K	15.39K	106K
Asset Writedown & Restructuring Costs	-	-	-	-	2.67M
Stock-Based Compensation (CF)	144K	266K	369K	326K	296K
Provision and Write-off of Bad Debts	-	-	-	-	-
Other Operating Activities, Total	10.72K	28.48K	95.72K	-150K	-285K
Change In Accounts Receivable	-897K	936K	-427K	-1.59M	352K
Change In Inventories	-997K	-2.95M	-1.77M	699K	-2.15M
Change In Accounts Payable	246K	342K	157K	363K	-195K
Change in Unearned Revenues	-	-	-	-	-
Change in Other Net Operating Assets	26.62K	-161K	-68.86K	117K	-55.23K
Cash from Operations	954K	-1.54M	-4.67M	358K	2.48M
Capital Expenditure	-2.61M	-3.98M	-1.89M	-466K	-1.25M
Sale of Property, Plant, and Equipment	15.29K	11K	2.47K	4.5K	36.13K
Cash Acquisitions	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	996K	-	-	-	-
Cash from Investing	-1.6M	-3.96M	-1.89M	-461K	-1.21M
Short Term Debt Issued, Total	-	-	2M	-	-
Long-Term Debt Issued, Total	400K	2M	3M	-	801K
Total Debt Issued	400K	2M	5M	-	801K
Short Term Debt Repaid, Total	-	-	-2M	-	-
Long-Term Debt Repaid, Total	-768K	-897K	-1.19M	-1.47M	-2.28M
Total Debt Repaid	-768K	-897K	-3.19M	-1.47M	-2.28M
Issuance of Common Stock	4.24M	30.67K	18.76K	4.65M	349K
Other Financing Activities, Total	2.27K	-19.31K	-81.53K	-297K	-82.51K
Cash from Financing	3.88M	1.11M	1.75M	2.88M	-1.21M
Net Change in Cash	3.24M	-4.39M	-4.81M	2.78M	48.6K
Supplemental Items
Cash Interest Paid	309K	339K	445K	529K	443K
Cash Income Tax Paid (Refund)	5.11K	4.92K	6.47K	7.29K	10.69K
Levered Free Cash Flow	-1.64M	-4.61M	-4.51M	1.03M	998K
Unlevered Free Cash Flow	-1.45M	-4.4M	-4.23M	1.34M	1.25M
Change In Net Working Capital	1.6M	1.74M	2.16M	435K	2.05M
Net Debt Issued / Repaid	-368K	1.1M	1.81M	-1.47M	-1.48M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	0.38	-3.22	-7.36	-1.73	3.49
Return on Total Capital	0.39	-3.35	-7.72	-1.83	3.69
Return On Equity %	-0.26	-7.92	-20.86	-8.21	-3.81
Return on Common Equity	-0.26	-7.92	-20.86	-8.21	-3.81
Margin Analysis
Gross Profit Margin %	44.98	41.19	25.16	31.51	41.4
SG&A Margin	21.98	29.37	29.89	21.45	21.54
EBITDA Margin %	14.13	1.02	-14.33	5.49	18.73
EBITA Margin %	1.44	-12.28	-29.77	-4.58	8.93
EBIT Margin %	1.34	-12.38	-29.88	-4.65	8.86
Income From Continuing Operations Margin %	-0.41	-13.43	-33.05	-8.14	-3.76
Net Income Margin %	-0.41	-13.43	-33.05	-8.14	-3.76
Net Avail. For Common Margin %	-0.41	-13.43	-33.05	-8.14	-3.76
Normalized Net Income Margin	-0.12	-8.39	-20.03	-4.07	4.79
Levered Free Cash Flow Margin	-8.5	-24.8	-25.81	3.88	3.61
Unlevered Free Cash Flow Margin	-7.52	-23.67	-24.24	5.06	4.53
Asset Turnover
Asset Turnover	0.45	0.42	0.39	0.6	0.63
Fixed Assets Turnover	0.69	0.63	0.56	0.85	1
Receivables Turnover (Average Receivables)	8.57	8.34	8.86	8.9	7.69
Inventory Turnover (Average Inventory)	4.09	2.39	1.89	2.43	1.98
Short Term Liquidity
Current Ratio	6.42	4.56	2.73	3.41	4.26
Quick Ratio	5.09	2.47	0.76	1.72	1.82
Operating Cash Flow to Current Liabilities	0.38	-0.5	-1.11	0.08	0.62
Days Sales Outstanding (Average Receivables)	42.59	43.77	41.2	41.14	47.47
Days Outstanding Inventory (Average Inventory)	89.34	152.57	193.32	150.52	184.54
Average Days Payable Outstanding	20.94	19.13	19.68	18.98	17.17
Cash Conversion Cycle (Average Days)	110.99	177.21	214.83	172.68	214.83
Long Term Solvency
Total Debt/Equity	31.54	41.08	66.78	54.87	48.77
Total Debt / Total Capital	23.98	29.12	40.04	35.43	32.78
LT Debt/Equity	28.71	37.55	58.49	47.86	42.5
Long-Term Debt / Total Capital	21.83	26.62	35.07	30.9	28.57
Total Liabilities / Total Assets	26.74	32.28	42.95	38.98	36.39
EBIT / Interest Expense	0.82	-6.6	-10.98	-2.17	4.96
EBITDA / Interest Expense	9.15	1.07	-4.45	3.43	11.47
(EBITDA - Capex) / Interest Expense	0.86	-10.33	-8.43	2.61	8.93
Total Debt / EBITDA	3.57	33.35	-7.88	7.75	2.33
Net Debt / EBITDA	0.03	17.87	-7.42	5.82	1.66
Total Debt / (EBITDA - Capex)	38.16	-3.47	-4.16	10.19	2.99
Net Debt / (EBITDA - Capex)	0.33	-1.86	-3.92	7.65	2.13
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	25.42	-3.51	-5.9	51.64	4.34
Gross Profit, 1 Yr. Growth %	26.13	-11.64	-46.63	89.89	44.13
EBITDA, 1 Yr. Growth %	181.15	-93.06	-422.01	-158.07	394.63
EBITA, 1 Yr. Growth %	-120.31	-924.57	207.66	-76.66	-252.27
EBIT, 1 Yr. Growth %	-118.65	-993.19	205.34	-76.38	-249.33
Earnings From Cont. Operations, 1 Yr. Growth %	-92.34	3.09K	131.56	-62.65	-51.78
Net Income, 1 Yr. Growth %	-92.34	3.09K	131.56	-62.65	-51.78
Normalized Net Income, 1 Yr. Growth %	-97.84	6.43K	194.05	-69.21	-199.4
Diluted EPS Before Extra, 1 Yr. Growth %	-92.72	3.02K	132.93	-64.79	-54.56
Accounts Receivable, 1 Yr. Growth %	49.95	-34.73	24.27	72.56	-9.34
Inventory, 1 Yr. Growth %	47.67	95.42	29.37	-8.95	30.29
Net Property, Plant and Equip., 1 Yr. Growth %	0.1	9.4	4.93	-6.96	-14.9
Total Assets, 1 Yr. Growth %	10.2	0.89	-2.35	2.95	-5.69
Tangible Book Value, 1 Yr. Growth %	15.42	-6.72	-17.76	10.23	-1.62
Common Equity, 1 Yr. Growth %	15.25	-6.74	-17.73	10.1	-1.68
Cash From Operations, 1 Yr. Growth %	-27.47	-261.8	202.76	-107.66	591.61
Capital Expenditures, 1 Yr. Growth %	-35.95	52.39	-52.39	-75.39	168.49
Levered Free Cash Flow, 1 Yr. Growth %	-24.13	181.56	6.4	-122.81	29
Unlevered Free Cash Flow, 1 Yr. Growth %	-27.67	203.74	5.14	-131.67	15.25
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	18.42	10.01	-4.71	19.45	25.79
Gross Profit, 2 Yr. CAGR %	13.33	5.57	-28.73	0.67	61.35
EBITDA, 2 Yr. CAGR %	43.86	-55.83	-4.03	36.74	43.81
EBITA, 2 Yr. CAGR %	-45.62	29.41	333.76	-15.26	-31.12
EBIT, 2 Yr. CAGR %	-48.06	29.05	350.39	-15.08	-31.51
Earnings From Cont. Operations, 2 Yr. CAGR %	-75.42	56.2	758.82	-7.01	-57.56
Net Income, 2 Yr. CAGR %	-75.42	56.2	758.82	-7.01	-57.56
Normalized Net Income, 2 Yr. CAGR %	-82.63	18.84	1.11K	-4.85	-38.5
Diluted EPS Before Extra, 2 Yr. CAGR %	-76.7	50.74	752.82	-9.44	-60
Accounts Receivable, 2 Yr. CAGR %	28.28	-1.07	-9.94	46.44	25.08
Inventory, 2 Yr. CAGR %	10.77	69.88	59	8.53	8.92
Net Property, Plant and Equip., 2 Yr. CAGR %	5.28	4.65	7.14	-1.19	-11.02
Total Assets, 2 Yr. CAGR %	7.2	5.44	-0.74	0.27	-1.47
Tangible Book Value, 2 Yr. CAGR %	6.11	3.76	-12.41	-4.79	4.14
Common Equity, 2 Yr. CAGR %	6	3.67	-12.41	-4.83	4.04
Cash From Operations, 2 Yr. CAGR %	102.14	8.33	121.33	-51.85	-27.23
Capital Expenditures, 2 Yr. CAGR %	36.92	-1.2	-14.83	-65.77	-18.71
Levered Free Cash Flow, 2 Yr. CAGR %	205.51	46.16	66.03	-50.74	-52.94
Unlevered Free Cash Flow, 2 Yr. CAGR %	331.75	48.22	71.05	-42.29	-45.62
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	20.54	10.6	4.43	11.25	14.19
Gross Profit, 3 Yr. CAGR %	18.56	4.31	-13.8	-1.2	11.58
EBITDA, 3 Yr. CAGR %	63.16	-47.63	37.33	-18.83	88.14
EBITA, 3 Yr. CAGR %	-49.35	34.6	56.34	63.75	13.44
EBIT, 3 Yr. CAGR %	-50.69	34.07	55.81	68.58	12.72
Earnings From Cont. Operations, 3 Yr. CAGR %	-67.69	24.39	78.1	202.01	-25.29
Net Income, 3 Yr. CAGR %	-67.69	24.39	78.1	202.01	-25.29
Normalized Net Income, 3 Yr. CAGR %	-75.39	25.38	46.93	256.16	3.61
Diluted EPS Before Extra, 3 Yr. CAGR %	-71.01	19.22	74.27	194.75	-28.04
Accounts Receivable, 3 Yr. CAGR %	42.44	2.41	6.74	11.86	24.81
Inventory, 3 Yr. CAGR %	9.84	33.85	55.13	32.04	15.35
Net Property, Plant and Equip., 3 Yr. CAGR %	2.47	6.64	4.74	2.22	-5.99
Total Assets, 3 Yr. CAGR %	10.75	5.05	2.78	0.47	-1.76
Tangible Book Value, 3 Yr. CAGR %	14.63	1.65	-3.97	-5.43	-3.74
Common Equity, 3 Yr. CAGR %	14.43	1.57	-4.02	-5.47	-3.79
Cash From Operations, 3 Yr. CAGR %	36.71	87.69	52.59	-27.88	17.04
Capital Expenditures, 3 Yr. CAGR %	8.72	41.89	-22.54	-43.69	-31.99
Levered Free Cash Flow, 3 Yr. CAGR %	-12.9	197.31	27.88	-14.34	-38.24
Unlevered Free Cash Flow, 3 Yr. CAGR %	-13.36	283.99	28.39	-2.51	-32.25
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	15.06	12.22	9.72	14.06	12.5
Gross Profit, 5 Yr. CAGR %	9.81	7.93	-3.28	4.37	10.77
EBITDA, 5 Yr. CAGR %	10.18	-22.19	31.96	2.05	39.88
EBITA, 5 Yr. CAGR %	-20.86	59.09	19.58	5.37	12.64
EBIT, 5 Yr. CAGR %	-21.98	56.76	19.45	5.27	12.15
Earnings From Cont. Operations, 5 Yr. CAGR %	-31.22	71.49	19.99	10.73	0.35
Net Income, 5 Yr. CAGR %	-31.22	71.49	19.99	10.73	0.35
Normalized Net Income, 5 Yr. CAGR %	-45	41.57	16.95	6.39	3.71
Diluted EPS Before Extra, 5 Yr. CAGR %	-38.79	56.8	12.13	6.8	-3.27
Accounts Receivable, 5 Yr. CAGR %	22.11	5.52	18.58	18.16	13.73
Inventory, 5 Yr. CAGR %	7.76	24.12	27.36	23.08	34.67
Net Property, Plant and Equip., 5 Yr. CAGR %	23.25	3.28	4.31	3.43	-1.87
Total Assets, 5 Yr. CAGR %	12.48	5.52	6	3.11	1.06
Tangible Book Value, 5 Yr. CAGR %	10.74	5.3	2.93	-0.98	-0.81
Common Equity, 5 Yr. CAGR %	10.56	5.18	2.82	-1.04	-0.87
Cash From Operations, 5 Yr. CAGR %	33.82	5.6	65.77	8.92	13.48
Capital Expenditures, 5 Yr. CAGR %	-8.43	-25.87	-1.39	-19.66	-21.03
Levered Free Cash Flow, 5 Yr. CAGR %	-13.36	-23.08	12.74	42.46	-14.27
Unlevered Free Cash Flow, 5 Yr. CAGR %	-14.94	-23.68	13.74	76.8	-8.94